Ocera Therapeutics Inc Stock

Stocks

17-11-02	Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Ocera Therapeutics, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
17-10-20	Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®	GL
17-08-23	Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017	GL
17-08-01	Ocera Therapeutics Reports Second Quarter 2017 Financial Results	GL
17-06-01	Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OCERA THERAPEUTICS INC	-.--%	+2.29%	-	-	0
REGENERON PHARMACEUTICALS, INC.	-1.67%	-4.78%	+36.76%	-4.34%	79.3B
CSL LIMITED	-0.90%	+2.39%	-19.06%	-35.50%	59.21B
MODERNA, INC.	-3.35%	-4.92%	+472.81%	+18.97%	55.09B
SAMSUNG BIOLOGICS CO.,LTD.	-6.78%	-4.19%	-3.45%	+28.35%	49.86B
UCB	-2.43%	-2.35%	+8.33%	+160.40%	47.9B
BIOGEN INC.	-1.35%	+0.79%	+65.25%	-18.47%	32.28B
INCYTE CORPORATION	-2.64%	-2.69%	+46.99%	+92.55%	25.21B
INNOVENT BIOLOGICS, INC.	-0.09%	+4.98%	+11.00%	+199.86%	23.87B
SWEDISH ORPHAN BIOVITRUM AB	-0.34%	+1.35%	+62.33%	+122.21%	16.89B
Average	-1.96%	-1.20%	+75.66%	+62.67%	43.29B
Weighted average by Cap.	-2.42%	-2.05%	+83.85%	+41.75%

Employees

Sector